CDER New August 13, 2015

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

August 12, 2015


New and Generic Drug Approvals

August 11, 2015

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Botox onabotulinumtoxina Vial; Single-Use Allergan Labeling Revision
Botox Cosmetic onabotulinumtoxina Vial; Single-Use Allergan Labeling Revision
Breo Ellipta fluticasone furoate; vilanterol trifenatate Powder;Inhalation Glaxo Grp Ltd Manufacturing Change or Addition
Brovana arformoterol tartrate Solution;Inhalation Sunovion Manufacturing Change or Addition
Copegus ribavirin Tablet;Oral Roche Labeling Revision
Delestrogen estradiol valerate Injectable;Injection Par Sterile Products Manufacturing Change or Addition
Helidac bismuth subsalicylate; metronidazole; tetracycline hydrochloride Tablet, Chewable, Tablet, Capsule;Oral Prometheus Labs Labeling Revision
Lazanda fentanyl citrate Spray, Metered;Nasal Depomed Inc Manufacturing Change or Addition
Onsolis fentanyl citrate Film;Buccal Biodelivery Sci Intl Manufacturing Change or Addition
Sivextro tedizolid phosphate Tablet;Oral Cubist Pharms Inc Manufacturing Change or Addition
Zelboraf vemurafenib Tablet;Oral Hoffmann La Roche Labeling Revision

 


This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

Postingan terkait:

Belum ada tanggapan untuk "CDER New August 13, 2015"

Post a Comment